Covovax/Nuvaxovid by Novavax is a protein subunit vaccine from virus-like particles.
coronavirus disease 2019
Posted inCOVID-19, Infections, New Drugs, Regulatory
Evusheld: First Drug for Strong and Long-Lasting Protection Against Coronavirus
One dose of AstraZeneca’s monoclonal antibody cocktail protects against COVID-19 for six months or longer.
Posted inCOVID-19, Infections, New Drugs, Regulatory
Covifenz: Medicago’s Plant-Derived COVID-19 Vaccine
Innovative Medicago’s vaccine is made by molecular pharming technology.
Posted inClinical Trials, COVID-19, Infections
Kropsen: Strong New Pill to Treat COVID-19 Infection
Oral proxalutamide by Chinese Kintor Pharmaceutical effectively treats COVID-19 in outpatients and inpatients.
Posted inClinical Trials, COVID-19, Infections, Research
Favipiravir to Treat COVID-19. Most Comprehensive Review in World
What benefit we should expect from favipiravir in the fight against coronavirus?
Posted inClinical Trials, COVID-19, Infections
Upamostat: Oral Medication for COVID-19
Upamostat by RedHill Biopharma prevents COVID-19 complications from developing followed by hospitalization or death.
Posted inClinical Trials, COVID-19, Infections, Oncology
Yeliva: New Drug for COVID-19
Oral opaganib will reduce the likelihood of death and accelerate recovery in hospitalized patients with COVID-19.
